文献速递胸部CT

双层光谱探测器CT影像组学特征预测浸润性肺腺癌程序性细胞死亡配体1表达

Dual-layer spectral detector CT radiomic features to predict programmed cell death ligand 1 expression in invasive lung adenocarcinoma.
PubMed 文献 · Br J Radiol · 2026-01-01

前瞻性纳入191例浸润性肺腺癌患者,基于术前双层光谱探测器CT的碘图、虚拟平扫和常规图像提取影像组学特征,结合病理分期构建列线图预测PD-L1表达(肿瘤比例评分≥1%为阳性)。碘图列线图在训练集AUC=0.791、验证集AUC=0.737,校准曲线和决策曲线分析证实其一致性和临床实用性。

要点

  • 碘图列线图预测PD-L1表达的验证集AUC=0.737,优于虚拟平扫和常规图像列线图。
  • PD-L1阳性定义为肿瘤比例评分≥1%,列线图整合影像组学评分与病理分期(pTNM)。
  • 双层光谱探测器CT列线图可能有助于个体化免疫治疗决策。

核心结论

  • 基于碘图的影像组学列线图对浸润性肺腺癌PD-L1表达具有个体化预测潜力,可能识别可从免疫治疗获益的候选者。

研究设计与样本

  • 前瞻性研究纳入191例浸润性肺腺癌患者,术前接受胸部增强双层光谱探测器CT扫描并进行PD-L1表达检测,采用最小绝对收缩和选择算子提取影像组学评分,通过逻辑回归整合影像组学评分与临床病理特征构建列线图。

诊断标准与关键数值

  • PD-L1阳性定义为肿瘤比例评分≥1%;碘图列线图训练集AUC=0.791、验证集AUC=0.737;虚拟平扫和常规图像列线图与碘图列线图一同基于病理分期(pTNM)构建,碘图列线图性能最优。

临床应用与阅片要点

  • 作者认为碘图列线图可能有助于浸润性肺腺癌PD-L1表达的个体化预测和免疫治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This prospective study aimed to develop and validate integrated nomograms that combine preoperative radiomic features from dual-layer spectral detector CT (DLCT) with key postoperative pathological information for the prediction of programmed cell death ligand 1 (PD-L1) expression in invasive lung adenocarcinoma.

METHODS: The study included 191 participants with invasive lung adenocarcinoma who underwent preoperative thoracic contrast-enhanced DLCT scans and PD-L1 expression testing. Radiomic features were extracted from various DLCT images. Least absolute shrinkage and selection operator was used to derive radscores for PD-L1 expression (tumor proportion score ≥1% was defined as PD-L1 positivity). Nomograms were developed by integrating radscores with clinicopathological characteristics through logistic regression analysis. Performance was assessed using receiver operator characteristic (ROC) curves, area under the curve (AUC), calibration curves, and decision curve analysis (DCA).

RESULTS: Three sets of radiomic nomograms, based on iodine map (IM), virtual non-contrast (VNC), and conventional images (PCI), along with pathological stages (pTNM), were developed. The IM nomogram exhibited superior performance in both training (AUC = 0.791) and validation (AUC = 0.737) sets. Calibration and DCA confirmed the IM nomogram's consistency and clinical utility.

CONCLUSIONS: The IM nomogram demonstrated potential for individualized prediction of PD-L1 expression in invasive lung adenocarcinoma and identify the candidates who may benefit from immunotherapy.

ADVANCES IN KNOWLEDGE: The nomogram based on dual-layer spectral detector CT can predict the probability of PD-L1 expression in invasive lung adenocarcinoma and may help personalized immunotherapy decisions.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang H, Ma Y, Li H, et al. Dual-layer spectral detector CT radiomic features to predict programmed cell death ligand 1 expression in invasive lung adenocarcinoma. Br J Radiol. 2026. PMID: 41844534. doi:10.1093/bjr/tqag064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。